Extensions

Patent Term and Family Analysis for U.S. Patent No. 8,949,206

Date of Analysis: May 11, 2026

An analysis of the public records for U.S. Patent No. 8,949,206 ("the '206 patent") provides the following details regarding its term, related applications, and international counterparts.

Key Dates:

• Filing Date: October 4, 2012
• Issue Date: February 3, 2015
• Legal Status: Active

---

Patent Term Adjustment (PTA) and Extensions (PTE)

• Patent Term Adjustment (PTA): There is no record of any Patent Term Adjustment (PTA) being granted for the '206 patent. The time from filing (October 4, 2012) to issuance (February 3, 2015) was approximately 2 years and 4 months, which is well within the 3-year period where USPTO delays might trigger a PTA.
• Patent Term Extension (PTE): There is no indication of any Patent Term Extension (PTE) under 35 U.S.C. § 156, which typically applies to delays in regulatory review for products like pharmaceuticals and is not relevant to this technology.

---

Continuity Data

A review of the patent's prosecution history and bibliographic data shows no "Continuity Data." This indicates that, as of its issuance, the '206 patent:

• Is Not a Continuation or Divisional: It does not claim priority to an earlier, co-pending U.S. non-provisional application.
• Has No Continuation or Divisional Applications: The patent owner has not filed any subsequent applications that claim the benefit of the '206 patent's filing date. This means there are no "child" applications that could issue with the same priority date but different claims.

---

Patent Family and Priority Claims

The '206 patent is part of a family of related patent documents filed in multiple jurisdictions, all claiming priority to the original U.S. application.

• Priority Application: The entire patent family claims priority to the U.S. application 13/644,792, filed on October 4, 2012.

• International (PCT) Application: A Patent Cooperation Treaty (PCT) application was filed as PCT/IB2013/059076 on October 2, 2013. This application was published as WO2014054012A1.

• Foreign Counterparts: Based on the priority claim, the following corresponding patent documents were filed in other national or regional patent offices:

  • China: CN104854877B
  • Europe: EP2904813A4

---

Projected Expiration Date

The term of a U.S. patent is typically 20 years from the filing date of the earliest U.S. or PCT application to which it claims priority.

• Base Expiration: 20 years from the filing date of October 4, 2012, places the expiration date at October 4, 2032.

• Adjusted Expiration: The "Legal Status" section provided in the patent data indicates an "Adjusted expiration" of December 12, 2032. This indicates there may have been a Patent Term Adjustment granted that is not immediately apparent in the basic bibliographic data. A detailed review of the file wrapper would be required to confirm the specific calculation of this adjustment.

Projected Expiration Date (Adjusted): December 12, 2032

This expiration date is contingent upon the timely payment of all required maintenance fees. The first maintenance fee (due at 3.5 years post-grant) was paid on August 3, 2018. The second fee (due at 7.5 years post-grant) would have been due by August 3, 2022, and the final fee (due at 11.5 years) will be due by August 3, 2026.